Abstract
In 30 patients on chronic haemodialysis treatment the platelet activity and function were studied before and during antiplatelet therapy with alpha-tocopherol and sulphinpyrazone. In both kinds of treatment a significant decrease of ADP-induced and spontaneous aggregation was observed. Sulphinpyrazone exerts an inhibitory effect not only on platelet aggregation but also on platelet factor 3 and provokes a significant prolongation of the bleeding time.
Similar content being viewed by others
References
Born, G. V. R.: Aggregation of blood platelets by adenosine diphosphate.Nature, 194, 927 (1962).
Breddin, K., Krzywanek, H. J., Bald, M., Kutschera, J.: Platelet aggregation control: clinical potential. In: Platelet Aggregation and Drugs. Academic Press, London 1974, p. 197.
Dworski, R., Domagała, B., Hartwich, J., Radwan, J., Grzywacz, M., Szeczeklik, A.: Vitamin E effect on plasma lipid peroxides and platelet aggregation in patients with hyperlipoproteinaemia.Pol. Arch. Med. Wewn., 393, 75 (1986).
Fitzgerald, G. A., Brash, A. R.: Endogenous prostacyclin and thromboxane biosynthesis during chronic vitamin E therapy in man.Ann. N.Y. Acad. Sci., 324, 209 (1982).
Graham, F. F., Wallis, R. B., Zelaschi, D.: The effect of sulphinpyrazone and its metabolites on platelet function in vitro and ex vivo.Haemostasis, 10, 165 (1981).
Huang, N., Lineberger, B., Steiner, M.: Alpha-tocopherol, a potent modulator of endothelial cell function.Thromb. Res., 50, 547 (1988).
Karpen, C. W., Pritchard, K. A., Arnold, J. H., Cornell, D. G., Parganamala, R. V.: Restoration of prostacyclin thromboxane A2 balance in the diabetic rat: influence of dietary vitamin E.Diabetes, 31, 947 (1982).
Lucy, J. A.: Functional and structural aspects of biological membranes. A suggested structural role for vitamin E in the control of membrane permeability and stability.Ann. N.Y. Acad. Sci., 4, 203 (1972).
Mielke, C. H.: Template bleeding time: technique. In: Platelet Function Testing. DHEW Publications, (NIH) 78-1087, 1977, p. 723.
Miesher, P. A., Gerard, W. H.: A one-step method for counting the leukocytes and platelets.Am. J. Clin. Pathol., 46, 576 (1966).
O'Brien, J. R., Etherington, M. D.: Heparin-thrombin clotting time and platelet factor 4.Lancet, 1, 656 (1974).
Preston, F. E., Greaves, M.: Platelet suppressive therapy in clinical medicine.Br. J. Haematol., 60, 589 (1985).
Saleem, A., Krieg, A., Cieślica, R.: Platelet activity ratio.Am. J. Clin. Pathol., 232, 1303 (1975).
Steiner, M., Anastasi, J.: Vitamin E—an inhibitor of platelet release reaction.J. Clin. Invest., 57, 752 (1976).
Steiner, M.: Effect of alpha-tocopherol administration on platelet function in man.Thromb. Haemost., 49, 73 (1983).
Szezeklik, A., Gryglewski, R. J., Domagała, B., Dworski, R., Basista, M.: Dietary supplementation with vitamin E in hyperlipoproteinemias. Effect on plasma lipid peroxides, antioxidant activity, prostacyclin generation and platelet aggregation.Thromb. Haemost., 54, 425 (1985).
Watanabe, J., Umeda, F., Wakasugi, H., Ibayashi, H.: Effect of vitamin E on platelet aggregation in diabetes mellitus.Thromb. Haemost., 51, 313 (1984).
Wu, K. K., Hoak, J. C.: A new method for the quantitative detection of platelet aggregates in patients with arterial insufficiency.Lancet, 2, 924 (1974).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dmoszyńska-Giannopoulou, A., Janicka, L., Sokołowska, B. et al. The effect of sulphinpyrazone and alpha-tocopherol on platelet activation and function in haemodialysed patients. International Urology and Nephrology 22, 561–566 (1990). https://doi.org/10.1007/BF02549745
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02549745